Limitations of the therapeutic use of superoxide dismutase Due to the instability, high immunogenicity, low cellular uptake and less in vivo circulation of the half-life of superoxide dismutase, their clinical use as therapeutic agents is very limited
Liposomes may fuse or leak under extreme acidity
the DPP-4 cohort
the Australian National Health and Medical Research Council through project grant 1160517 to T Thomas, Ideas Grant 2010711 to T Thomas, Research Fellowships 1081421 to AK Voss and 1154970 to GK Smyth, and Investigator Grants 1176789 to AK Voss and 1194345 to ME Blewitt
Additionally, numerous pro-inflammatory changes have been observed in the lungs of smokers, with inflammation closely linked to tumor promotion and the activation of factors like NFB [136,137,138]
During the briefing, Pitts also criticized media companies for running advertisements for counterfeit GLP-1s